Nov 08, 2022 / 06:25PM GMT
Unidentified Analyst -
So in our next session, we have Veracyte, Marc Stapley, CEO; Rebecca Chambers, CFO. Thank you both for joining us. I'm Dan Leonard, the diagnostics analyst at Credit Suisse and happy to kick things off and learn more about Veracyte.
Marc, I think you wanted to start with the safe harbor statement?
Marc A. Stapley - Veracyte, Inc. - CEO & Director
Yes. Thanks, Dan, and thanks for having us here today. It's a real pleasure to be here at this conference. And yes, I would like to refer investors to our safe harbor statement that can be found on our corporate website, in our corporate presentation, www.veracyte.com, to the extent we make forward-looking statements that are intended to be covered by the safe harbor statement.
Questions and Answers:
Unidentified Analyst -Look forward to that. So before we get off and start talking about forward-looking statements, Marc, can you give us a brief overview of Veracyte for folks who aren